Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Membrane phospholipid acyl chains are the hydrophobic fatty acid components that constitute the internal core of the biological lipid bilayer. These chains play a fundamental role in determining the physical properties of the cell membrane, such as its fluidity, thickness, and the environment in which integral membrane proteins function (Source: NIH, PubMed). They are critical in disease states like cancer, where altered lipid saturation levels affect cell survival and signaling, and in neurodegeneration, where the peroxidation of polyunsaturated fatty acid chains leads to ferroptotic cell death (Source: Nature Reviews Molecular Cell Biology). Pharmacologically, these chains are targeted by various agents; for example, daptomycin inserts into the acyl chain region to disrupt bacterial membranes, and antioxidants like Ferrostatin-1 protect these chains from oxidative damage (Source: PubChem, PubMed). Because they are ubiquitous, therapeutic strategies often focus on the specific chemical vulnerabilities of certain chain types, such as the susceptibility of polyunsaturated chains to oxidation in specific pathological contexts.
Drugs targeting membrane phospholipid acyl chains typically act by disrupting membrane integrity, modulating membrane fluidity, or inhibiting lipid peroxidation. For instance, antimicrobial peptides insert into the hydrophobic core to cause pore formation, while ferroptosis inhibitors prevent the oxidative degradation of polyunsaturated fatty acid (PUFA) chains. Some anesthetics are thought to partition into these chains, altering the lateral pressure and affecting the function of embedded ion channels.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane phospholipid acyl chains (Phospholipid acyl chains).